Aarti Drugs Share Price

ABOUT Aarti Drugs

• Industry Biotechnology & Drugs
• ISIN INE767A01016
• BSE Code 524348
• NSE Code AARTIDRUGS

Aarti Drugs Limited is an India-based company, which is engaged in the manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and formulations. The Company operates in the pharmaceuticals segment. Its geographical segments include Out of India and India. The Company's APIs products include iprofloxacin hydrochloride, metronidazole, metformin HCL, ketoconazole, ofloxacin, and others. Its specialty chemicals include benzene sulphonyl chloride, methyl nicotinate, among others. Its pharma intermediates products include tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, raloxifene and zolpidem. Its products under development include alpha lipoic acid, itraconazole, ticagrelor, and sitagliptin. The Company's subsidiaries include Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited, and Pinnacle Chile SPA.

MANAGEMENT

• Prakash Patil Chairman of the Board, Chief Executive Officer, Managing Director, Executive Director
• Adhish Patil Chief Financial Officer, Chief Operating Officer
• Rushikesh Deole Compliance Officer, Company Secretary
• Harshit Savla Joint Managing Director, Executive Director
• Rashesh Gogri Managing Director, Executive Director
• Uday Patil Executive Director
• Harit Pragji Shah Executive Director